Pharmalive - The Pulse of the Pharmaceutical Industry
Search Criteria: Search In:  
Conferences


R&D Directions Insider

Wave of momentum for cancer immunotherapies

Friday, June 4th, 2010

Since the landmark approval of Provenge in late April for prostate cancer, much has been made of the significant buzz created for similar cancer immunotherapies (see stories here and here) that stimulate a patient’s immune system to recognize, attack, and kill tumor cells. Clinical data for a new wave of ...

Posted in antibodies, cancer, clinical trials | No Comments »

Lupus drought: 50 years and counting

Thursday, October 8th, 2009

In this month’s issue of R&D Directions, we examine the 10 most active areas of therapeutic research, and also highlight some promising therapies for diseases in these categories. One condition researchers are particularly hesitant to lump into that “promising” group is lupus – and who could blame them? There have ...

Posted in Uncategorized, antibodies, clinical trials | 1 Comment »

Old MacDonald’s Pharma: Part 2

Wednesday, February 18th, 2009

Goats are not the only animals being used to develop new drugs. As The Wall Street Journal reported on Tuesday, llamas are being used to discover treatments for diseases such as rheumatoid arthritis, cancer, and Alzheimer’s disease. These pack animals and their relatives- camels and alpacas, naturally create very small antibodies ...

Posted in animals, antibodies, cancer | 1 Comment »

   
about us | advertise | contact us | home
terms of use | privacy | copyright | site map 		©2012 UBM Canon